Correlation Between Esperion Therapeutics and Agenus
Can any of the company-specific risk be diversified away by investing in both Esperion Therapeutics and Agenus at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Esperion Therapeutics and Agenus into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Esperion Therapeutics and Agenus Inc, you can compare the effects of market volatilities on Esperion Therapeutics and Agenus and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Esperion Therapeutics with a short position of Agenus. Check out your portfolio center. Please also check ongoing floating volatility patterns of Esperion Therapeutics and Agenus.
Diversification Opportunities for Esperion Therapeutics and Agenus
-0.79 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Esperion and Agenus is -0.79. Overlapping area represents the amount of risk that can be diversified away by holding Esperion Therapeutics and Agenus Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Agenus Inc and Esperion Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Esperion Therapeutics are associated (or correlated) with Agenus. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Agenus Inc has no effect on the direction of Esperion Therapeutics i.e., Esperion Therapeutics and Agenus go up and down completely randomly.
Pair Corralation between Esperion Therapeutics and Agenus
Given the investment horizon of 90 days Esperion Therapeutics is expected to generate 0.77 times more return on investment than Agenus. However, Esperion Therapeutics is 1.31 times less risky than Agenus. It trades about 0.31 of its potential returns per unit of risk. Agenus Inc is currently generating about -0.08 per unit of risk. If you would invest 203.00 in Esperion Therapeutics on September 2, 2024 and sell it today you would earn a total of 77.00 from holding Esperion Therapeutics or generate 37.93% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Esperion Therapeutics vs. Agenus Inc
Performance |
| Timeline |
| Esperion Therapeutics |
| Agenus Inc |
Esperion Therapeutics and Agenus Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Esperion Therapeutics and Agenus
The main advantage of trading using opposite Esperion Therapeutics and Agenus positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Esperion Therapeutics position performs unexpectedly, Agenus can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Agenus will offset losses from the drop in Agenus' long position.| Esperion Therapeutics vs. Elanco Animal Health | Esperion Therapeutics vs. SIGA Technologies | Esperion Therapeutics vs. Catalent | Esperion Therapeutics vs. ANI Pharmaceuticals |
| Agenus vs. Tff Pharmaceuticals | Agenus vs. Eliem Therapeutics | Agenus vs. Inhibrx | Agenus vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |